Going anti-Viral

Introducing Going anti-Viral, the podcast of the IAS–USA, a professional continuing medical education organization focused on HIV and other viral diseases. I’m Dr Michael Saag, professor emeritus of medicine and infectious diseases at the University of Alabama at Birmingham and volunteer member of the IAS–USA Board of Directors. Join us as we interview experts in viral medicine about their area of specialty and current developments in the field. Other episodes are drawn from the IAS-USA vast catalogue of panel discussions, Dialogues, and various meetings and conferences. Going anti-Viral is a podcast series for clinicians, produced by the International Antiviral Society–USA. The IAS–USA is a not-for-profit professional organization committed to improving the treatment, care, and quality of life for people with or at risk for HIV or other viral infections and their complications through balanced education and information. This podcast is intended as a clinical source of inf

Going anti-Viral is a health podcast hosted by Unknown Host, with 85 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts Going anti-Viral, a health show with 85 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #84

  How USAID Was Dismantled—and What the World Lost - Nicholas Enrich

  Aug 14, 202644 minS1

  In episode 84 of Going anti -Viral, Nicholas Enrich joins host Dr Michael Saag to discuss his book Into the Wood Chipper: A Whistleblower's Account of How the Trump Administration Shredded USAID. Mr Enrich is a former civil servant who worked at the United States Agency for International Development (USAID) under 4 administrations. He served as the Bureau of Global Health director of policy, programs, and planning until January 2025, when he was designated as the USAID acting assistant administrator for global health. On March 2, 2025, he was placed on administrative leave for addressing the Trump administration dismantling of USAID. Mr Enrich provides an overview of the history and work of USAID prior to 2025 including the success of programs like the US President's Emergency Plan for AIDS Relief (PEPFAR) and nutrition and food security programs. He then shares his firsthand account of the dismantling of USAID under the Trump administration including the actions by political appointees and staff from the Department of Government Efficiency (DOGE). Mr Enrich and Dr Saag explore the impact of the Administration’s policy on global health, development, and international partnerships and discuss the long-term consequences of the dismantling of USAID. 0:00 – Introduction 1:17 – What was USAID and its global impact before 2025 3:00 – USAID work in global health and food security 5:10 – The inception and impact of PEPFAR 8:07 – US politics and the continuity of USAID during the first Trump Administration 13:29 – The executive order to freeze foreign aid and its implications 15:37 – Legal questions around the executive order and appropriations law 18:24 – Experience with DOGE and the management style of Elon Musk 21:30 – Stories of chaos by the DOGE team and destruction within USAID 26:17 – How the political leadership of USAID was unaware of the work of the agency and implications on current health outbreaks like Ebola 32:10 – The long-term consequences of dismantling USAID and rebuilding trust 40:33 – Nicholas Enrich's current work and future plans Resources: Into the Wood Chipper: A Whistleblower's Account of How the Trump Administration Shredded USAID https://www.simonandschuster.com/books/Into-the-Wood-Chipper/Nicholas-Enrich/9781668226957 Cast of Hair perform Let The Sunshine In on The Ed Sullivan Show, March 30, 1969 https://www.youtube.com/watch?v=rCXSA_biSw4&t=200s __________________________________________________ Produced by IAS-USA, Going anti –Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti- Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode. Follow Going anti-Viral on: Apple Podcasts YouTube X Facebook Instagram ...

  ListenShow Notes
• 

  Episode #83

  New Guidelines for Statin Use in People with HIV – REPRIEVE Trial Updates - Dr Steven Grinspoon

  Jul 28, 202628 minS1

  In episode 83 of Going anti -Viral, Dr Steven Grinspoon joins host Dr Michael Saag to provide an update on guidelines for statin use in people with HIV based on results from the REPRIEVE trial. Dr Grinspoon is a Professor of Medicine at Harvard Medical School and a clinician in the Neuroendocrine and Pituitary Tumor Clinical Center and faculty member at the Massachusetts General Hospital. He is a clinical researcher who studies hypothalamic control of body weight and fat distribution in obesity and lipodystrophy with a focus on the metabolic and cardiovascular consequences of visceral fat accumulation. Dr Grinspoon is the author of more than 200 peer-reviewed publications and serves as the chief of the Massachusetts General Metabolism Unit and the director of the Nutrition Obesity Research Center at Harvard. Dr Grinspoon and Dr Saag discuss the latest findings from the REPRIEVE trial and provide updates on statin guidelines for people with HIV as well as providing insights into cardiovascular risk management. They discuss the safety and efficacy of statins and the role of cardiovascular risk calculators in clinical practice in addition to discussing the impact of low-density lipoprotein (LDL) cholesterol and inflammation on cardiovascular risk. Dr Grinspoon also offers his outlook for where further research is needed based on the outcomes of the REPRIEVE trial. 0:00 – Introduction 1:33 – Overview of the REPRIEVE trial findings 2:44 – Changes in statin guidelines for people with HIV 6:51 – Safety and efficacy of statins 9:09 – Use of statins and diabetes risk 11:16 – Cardiovascular risk calculators 16:00 – Statin use and blood pressure 17:14 – Impact of LDL cholesterol and inflammation on cardiovascular risk 24:08 – Future directions in cardiovascular research for people with HIV Resources: Going anti -Viral: Episode 56 – Cardiovascular Health in People with HIV – Dr Steven Grinspoon Apple Podcasts: https://podcasts.apple.com/us/podcast/the-management-of-cardiovascular-health-in-patients/id1713226144?i=1000725697103 YouTube: https://youtu.be/297vweZ5bjQ REPRIEVE Trial : https://www.reprievetrial.org/ __________________________________________________ Produced by IAS-USA, Going anti –Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti- Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode. Follow Going anti-Viral on: Apple Podcasts YouTube X Facebook Instagram ...

  ListenShow Notes
• 

  Episode #82

  Tracking Ebola — Outbreak Status and the International Response - Dr Tyler Evans

  Jul 14, 202632 minS1

  In episode 82 of Going anti -Viral, Dr Tyler Evans joins host Dr Michael Saag to discuss the Ebola outbreak in the Democratic Republic of the Congo and Uganda and the global response. Dr Evans is an infectious diseases and addiction medicine physician and CEO of Wellness Equity Alliance, a national organization advancing health equity in the US and globally. He is also an associate professor of population and public health sciences at the University of Southern California Keck School of Medicine and the author of Pandemics, Poverty, and Politics , which examines how socially and politically determined inequalities, have consistently precipitated pandemics and public health emergencies. Dr Evans’ work spans street medicine, HIV/AIDS care, and humanitarian response in complex emergencies, including 2 Ebola response missions. Dr Evans and Dr Saag discuss the current Ebola outbreak, its transmission, challenges in containment, and the likelihood for a vaccine. They also explore the impact of public trust on care and provide an update on the response from US and international agencies including a discussion of the risk for the outbreak to spread globally. 0:00 – Introduction 1:33 – Understanding Ebola: transmission and symptoms 3:05 – Containment strategies for Ebola outbreaks 7:39 – Challenges in surveillance and response 11:09 – Urban spread of Ebola: risks and concerns 12:43 – Vaccination strategies and developments 15:58 – Conditions in treatment centers and the impact of public trust in the outbreak 21:04 – Update on the response from US and international agencies and risk of spread to the US and globally Resources: Pandemics, Poverty, and Politics: https://www.tylerevansmd.com/ Wellness Equity Alliance: https://www.wellnessequityalliance.com/ __________________________________________________ Produced by IAS-USA, Going anti –Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti- Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode. Follow Going anti-Viral on: Apple Podcasts YouTube X Facebook Instagram ...

  ListenShow Notes
• 

  Episode #81

  Progress in HIV Cure Research: Can a Single Shot Deliver a Functional Cure? - Dr Steven Deeks

  Jun 30, 202632 minS1

  In episode 81 of Going anti -Viral, Dr Steven Deeks joins host Dr Michael Saag to discuss recent research demonstrating the promise of a single shot in a functional cure of HIV. Dr Deeks is a Professor of Medicine in Residence at the University of California, San Francisco (UCSF) and is a faculty member in the Division of HIV, Infectious Diseases and Global Medicine at Zuckerberg San Francisco General Hospital. He is an internationally recognized expert on HIV pathogenesis and treatment and is the contact principal investigator of the Delaney AIDS Research Enterprise (DARE), an NIH-funded international collaboratory aimed at developing therapeutic interventions to cure HIV infection. Dr Deeks and Dr Saag discuss why a cure for HIV is needed given the effectiveness antiretroviral therapy. Dr Deeks then outlines areas of research demonstrating promise for single-shot functional cures: vector immunotherapy, the use of Chimeric Antigen Receptor (CAR) T cells, and stem cell approaches. Finally, Dr Deeks provides insights into future prospects in HIV cure research including his perspective on the funding and drug development landscape. 0:00 – Introduction 1:21 – The need for a cure beyond antiretroviral therapy 5:37 – Overview of 1-shot cure research 12:40 – The promise of vector immunotherapy 18:52 – Overview of the use of CAR-T cells 25:01 – The role of C-C chemokine receptor type 5 (CCR5) and stem cell approaches 26:36 – Prospects for the future of HIV cure research __________________________________________________ Produced by IAS-USA, Going anti –Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti- Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode. Follow Going anti-Viral on: Apple Podcasts YouTube X Facebook Instagram ...

  ListenShow Notes
• 

  Episode #80

  TMVII: Understanding the Emergence of Trichophyton mentagrophytes Genotype VII – Dr Jason Zucker

  Jun 16, 202620 minS1

  In episode 80 of Going anti -Viral, Dr Jason Zucker joins host Dr Michael Saag to provide an update on the Trichophyton mentagrophytes genotype VII (TMVII) infection. Dr Zucker is an Assistant Professor of Medicine at Columbia University and Assistant Medical Director of the New York City STD Prevention Training Center. Dr Zucker is an experienced HIV, HIV prevention, and sexual health care provider providing status-neutral care to patients of all ages in New York. His research focuses on the intersection of data science, behavioral science, and implementation science. Dr Zucker discusses the emerging dermatophyte infection TMVII, its transmission, clinical presentation, and diagnosis. Dr Zucker and Dr Saag also detail treatment strategies, emphasizing the significance in sexual health and STI management. 0:00 – Introduction 1:21 – Background, epidemiology and transmission 5:58 – Clinical presentation and diagnosis 9:18 – Treatment protocols for TMVII 11:32 – Challenges and considerations in management of TMVII 15:38 – Future outlook and final thoughts Resources : Morbidity and Mortality Weekly Report (MMWR) - Notes from the Field: Trichophyton mentagrophytes Genotype VII — New York City, April–July 2024 https://www.cdc.gov/mmwr/volumes/73/wr/mm7343a5.htm Going anti -Viral: Episode 30 - Update on Mpox - a Public Health Emergency - Dr Jason Zucker YouTube: https://youtu.be/GTwXSvkcJ74 Apple Podcasts: https://podcasts.apple.com/us/podcast/episode-30-update-on-mpox-a-public-health-emergency/id1713226144?i=1000675771251 __________________________________________________ Produced by IAS-USA, Going anti –Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti- Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode. Follow Going anti-Viral on: Apple Podcasts YouTube X Facebook Instagram ...

  ListenShow Notes

Recent guests on Going anti-Viral. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.